Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study
- on behalf of the ELECT Study Group
Research output: Contribution to journal › Article › peer-review
22
Link opens in a new tab
Scopus
citations